Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA intercalation is the process by which certain molecules, typically planar aromatic compounds known as intercalators, insert themselves between adjacent base pairs of the DNA double helix. This insertion disrupts the normal structure of DNA by unwinding and elongating the helix, inhibiting replication and transcription. Intercalating agents are widely used in chemotherapy for cancer treatment.
Intercalation involves the insertion of planar molecules between DNA base pairs, leading to unwinding and elongation of the DNA helix, thereby disrupting replication and transcription.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Intercalation.